Impact of excision repair cross-complementation group 1 (ERCC1) protein on survival of patients with osteosarcoma treated with cisplatin-based chemotherapy.
Kentaro Igarashi
No relevant relationships to disclose
Norio Yamamoto
No relevant relationships to disclose
Toshiharu Shirai
No relevant relationships to disclose
Katsuhiro Hayashi
No relevant relationships to disclose
Hideji Nishida
No relevant relationships to disclose
Hiroaki Kimura
No relevant relationships to disclose
Akihiko Takeuchi
No relevant relationships to disclose
Shinji Miwa
No relevant relationships to disclose
Hiroyuki Inatani
No relevant relationships to disclose
Shingo Shimozaki
No relevant relationships to disclose
Takashi Kato
No relevant relationships to disclose
Hiroyuki Tsuchiya
No relevant relationships to disclose